Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study

Peter Hillmen, Andy C Rawstron, Kristian Brock, Sam Munoz Vicente, Frankie Yates, Rebecca Bishop, Becky Boucher, Donald McDonald, Chris Fegan, Alison McCaig, Anna Schuh, Andrew Pettitt, John Gribben, Piers Patten, Stephen Devereux, Adrian Bloor, Christopher Fox, Francesco Forconi, Talha Munir

Cancer Clinical Trials Unit

Research output: Contribution to journal › Article › peer-review

71 Citations (Scopus)

325 Downloads (Pure)

1 results

Active
Assessment of the Mechanism of Action of Venetoclax (ABT-199) in combination with Ibrutinib (PCI-32765) in relapsed/refractory Chronic Lymphocytic Leukaemia (CLARITY)
Brock, K. & Siddique, S.
Janssen-Cilag Limited, Abbvie Ltd, BLOODWISE
1/01/16 → 31/05/24
Project: Research